Venom of Viperidae: A Perspective of its Antibacterial and Antitumor Potential

Curr Drug Targets. 2022;23(2):126-144. doi: 10.2174/1389450122666210811164517.

Abstract

The emergence of multi-drug resistant bacteria and limitations on cancer treatment represent two important challenges in modern medicine. Biological compounds have been explored with a particular focus on venoms. Although they can be lethal or cause considerable damage to humans, venom is also a source rich in components with high therapeutic potential. Viperidae family is one of the most emblematic venomous snake families and several studies highlighted the antibacterial and antitumor potential of viper toxins. According to the literature, these activities are mainly associated to five protein families - svLAAO, Disintegrins, PLA2, SVMPs and C-type lectins- that act through different mechanisms leading to the inhibition of the growth of bacteria, as well as, cytotoxic effects and inhibition of metastasis process. In this review, we provide an overview of the venom toxins produced by species belonging to the Viperidae family, exploring their roles during the envenoming and their pharmacological properties, in order to demonstrate its antibacterial and antitumor potential.

Keywords: Viperidae venoms; antibacterial; antitumor.; cancer; multi-drug resistant bacteria; toxins.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Disintegrins
  • Humans
  • Toxins, Biological*
  • Viper Venoms / pharmacology
  • Viperidae*

Substances

  • Anti-Bacterial Agents
  • Disintegrins
  • Toxins, Biological
  • Viper Venoms